AI-assisted care with a human safety net
Every health plan and employer evaluating a mental health AI tool asks the same first question: what happens when a member is in crisis? This page answers that question completely and without hedging — including what Neurodex does, what it escalates within 3 minutes to a licensed clinician, and what conditions it explicitly does not treat.
Specific signals. Specific responses. Not a chatbot safety message.
Neurodex's crisis detection is not pattern-matching to a list of keywords. It is a structured clinical protocol built around validated instruments and specific behavioral signals. When a threshold is crossed, the response is a human clinician — not a scripted message with a crisis hotline number.
Signals monitored in every session
Designed with HIPAA controls. Not claiming certification that doesn't exist.
Neurodex is designed with HIPAA technical and administrative controls in mind. We sign a Business Associate Agreement as part of our standard contract. All session data is encrypted end-to-end. Access logging and audit trails are maintained for compliance review.
We do not claim "HIPAA certified" status — no such certification currently exists for AI-assisted mental health platforms. What we have: BAA-ready contracts, encryption at rest and in transit, strict data minimization (no PHI in aggregate reports), role-based access controls, and documented breach notification procedures.
Grounded in 40 years of CBT research. No improvisation.
Neurodex's session content is built on the evidence base established by Aaron Beck's cognitive therapy framework and extended through decades of randomized controlled trials. The AI delivers structured, validated CBT protocols — it does not improvise therapy or generate novel clinical interventions.
Assessment instruments used: PHQ-9 (Patient Health Questionnaire — 9 items, scored 0–27 for depression severity), GAD-7 (Generalized Anxiety Disorder scale — 7 items, scored 0–21), and PHQ-4 (ultra-brief 4-item combined screener used for rapid triage). All are validated, widely published, and recognized by medical directors and clinical reviewers across health plans and EAPs.
"Neurodex is a structured CBT support tool. It is not a substitute for psychiatry, medication management, or emergency mental health services."
"CBT reduces moderate depression symptoms in 61% of patients — research consensus across meta-analyses of over 115 randomized controlled trials."
"Behavioral activation alone produces comparable outcomes to full CBT protocols for mild-to-moderate depression in multiple comparative effectiveness studies."
"Digital CBT interventions achieve effect sizes of 0.50–0.80 for depression and anxiety outcomes when structured and evidence-based."
Conditions outside Neurodex's scope
We state our limitations explicitly — at onboarding, in our sales process, and here. Neurodex is not the right tool for every mental health presentation. When a member's needs exceed our scope, we help them find appropriate care.
Outside Neurodex's treatment scope
Referral pathways for out-of-scope members
When intake assessment or session signals indicate that a member's needs exceed our scope, Neurodex:
Questions your clinical reviewer will ask. Answered here.
Schedule a clinical review call. We'll walk your medical director or clinical reviewer through the escalation protocol, HIPAA controls documentation, and scope boundaries.